calendar
2,355 catalysts · 3,728 phase readout · 2,108 8k filing · 276 earnings · 172 phase 2 completion · 138 grant · 133 drug shortage
2,355 catalysts · 3,728 phase readout · 2,108 8k filing · 276 earnings · 172 phase 2 completion · 138 grant · 133 drug shortage
no tagged catalysts yet
Sponsor: JANSSEN PHARMS. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: MICRO LABS. Form: TABLET. Route: ORAL
Sponsor: TIANJIN TIANYAO. Form: TABLET. Route: ORAL
Sponsor: TORRENT PHARMS. Form: TABLET. Route: ORAL
Sponsor: TORRENT PHARMS. Form: TABLET. Route: ORAL
Sponsor: TORRENT PHARMS. Form: TABLET. Route: ORAL
Sponsor: TORRENT PHARMS. Form: TABLET. Route: ORAL
Sponsor: SANDOZ. Form: INJECTABLE. Route: INJECTION
Sponsor: GLENMARK PHARMS LTD. Form: TABLET. Route: ORAL
Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION
Sponsor: SCIEGEN PHARMS. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: SANDOZ. Form: TABLET. Route: ORAL
Sponsor: STRIDES PHARMA INTL. Form: FOR SUSPENSION. Route: ORAL
Supplement type: Real-Time Process. Product code: LWS. Advisory committee: CV. Decision: APPR
Supplement type: Normal 180 Day Track No User Fee. Product code: MWG. Advisory committee: CV. Decision: APPR
Supplement type: Real-Time Process. Product code: QZH. Advisory committee: TX. Decision: APPR
Supplement type: Real-Time Process. Product code: NIK. Advisory committee: CV. Decision: APPR
Supplement type: Real-Time Process. Product code: LWS. Advisory committee: CV. Decision: APPR
Supplement type: Real-Time Process. Product code: LWS. Advisory committee: CV. Decision: APPR
Supplement type: Normal 180 Day Track No User Fee. Product code: NAW. Advisory committee: RA. Decision: APPR
Supplement type: 30-Day Notice. Product code: MRA. Advisory committee: OR. Decision: OK30
Supplement type: 30-Day Notice. Product code: QPY. Advisory committee: PM. Decision: OK30
Supplement type: Real-Time Process. Product code: LWP. Advisory committee: CV. Decision: APPR
Supplement type: Real-Time Process. Product code: NVN. Advisory committee: CV. Decision: APPR
Supplement type: Normal 180 Day Track. Product code: DSQ. Advisory committee: CV. Decision: APPR
Supplement type: Real-Time Process. Product code: LWS. Advisory committee: CV. Decision: APPR
Supplement type: Special (Immediate Track). Product code: NPW. Advisory committee: CV. Decision: APPR
Supplement type: Real-Time Process. Product code: NVN. Advisory committee: CV. Decision: APPR
Supplement type: Real-Time Process. Product code: QFV. Advisory committee: CV. Decision: APPR
Supplement type: Special (Immediate Track). Product code: QQK. Advisory committee: GU. Decision: APPR
Supplement type: 30-Day Notice. Product code: NJL. Advisory committee: OR. Decision: OK30
EB grant. $217,500. PI: Kawin Setsompop
HL grant. $186,613. PI: Kristine Karkoska
AI grant. $215,758. PI: Margaret E Ackerman
AI grant. $158,500. PI: Alexander L Dent
HL grant. $140,809. PI: Diana Sa Da Bandeira
AI grant. $440,949. PI: Isaura Simoes
AI grant. $372,997. PI: Kislay Parvatiyar
CA grant. $384,630. PI: John Justin Milner
AI grant. $787,837. PI: Seth Blumberg
CA grant. $10,000. PI: WILLIAM B COLEMAN
EB grant. $594,748. PI: Tod Edward Kippin
CA grant. $703,071. PI: Saar Gill
ES grant. $1,256,897. PI: VAIA LIDA CHATZI
AI grant. $791,611. PI: Jonathan D. Kurtis
AI grant. $538,838. PI: ADAM J CHICCO
CA grant. $772,208. PI: Jennifer L. Guerriero
AT grant. $167,400. PI: Joshua Solomon Greene
HG grant. $143,329. PI: Remy Furrer
AI grant. $598,906. PI: Marc B. Hershenson